S. Moulopoulos

After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptoki

R. Diaz, H. White, F. Werf, 1993, Circulation.

After Correcting for Worse Baseline Characteristics, Women Treated With Thrombolytic Therapy for Acute Myocardial Infarction Have the Same Mortalit and Morbidit as Men Except for a Higher Incidence of Hemorrhagic Stroke

R. Diaz, F. Van de Werf, H. White, 1993 .

Outcome of Thrombolytic Therapy in Relation to Hospital Size and Invasive Cardiac Services

R. Diaz, H. White, F. Werf, 1994 .

Significance of Smoking in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction Experience Gleaned From the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

R. Diaz, H. White, F. Werf, 1993, Circulation.

Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

R. Diaz, H. White, J. Hampton, 1995, European heart journal.

Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

R. Diaz, H. White, J. Hampton, 1994, Archives of internal medicine.

Coronary flow supplementation in experimental myocardial infarction with shock.

S. Moulopoulos, Y. Wu, W. Kolff, 1972, Chest.